Peptide History intermediate
History of Peptide Regulation
How regulatory frameworks for peptide drugs evolved from early insulin to modern CMC guidelines.
By Encyclopeptide Editorial | 1 min read
regulation fda ema history
Overview
Regulatory frameworks for peptide drugs have evolved significantly since insulin’s early days, with peptides now occupying a unique space between small molecules and biologics.
Key Milestones
- 1920s: First insulin quality standards
- 1960s: FDA begins formal peptide drug regulation
- 1980s: Recombinant insulin sets biologics precedent
- 1990s: ICH guidelines for peptide synthesis
- 2000s: ANDA pathway for peptide generics
- 2010s: Biosimilar frameworks applied to peptides
- 2020s: FDA and EMA converge on peptide guidelines
Impact
Peptides are regulated as drugs rather than biologics in most jurisdictions, simplifying approval pathways compared to antibody therapeutics.
References
- Source: ENCP Peptide Database
- Category: Peptide History
Test Your Knowledge
Reinforce what you learned about History of Peptide Regulation with interactive quizzes on Wikipept.
Take a Quiz on Wikipept